1. Clinical Overview
A fixed-dose combination (FDC) therapy primarily indicated for the management of painful diabetic peripheral neuropathy (DPN). Epalrestat is an aldose reductase inhibitor that targets the polyol pathway, a key contributor to diabetic nerve damage. Methylcobalamin is an active form of Vitamin B12 that supports nerve regeneration and myelin synthesis. Pregabalin is a gabapentinoid that modulates calcium channels to provide central analgesic and neuropathic pain relief. This combination offers a multi-modal approach targeting both the underlying pathophysiology and symptomatic pain relief in diabetic neuropathy.
| Onset | Duration | Bioavailability |
|---|---|---|
| Pregabalin: 1-2 hours for pain relief. Epalrestat & Methylcobalamin: Therapeutic benefits on nerve function may take 4-8 weeks. | Pregabalin: 8-12 hours (dose-dependent). Epalrestat: ~12 hours. Methylcobalamin: Prolonged tissue storage. | Pregabalin: ≥90%. Epalrestat: ~80%. Methylcobalamin: Oral bioavailability is low (~1-5%), but the 1500mcg dose is designed to overcome this via passive diffusion. |
2. Mechanism of Action
The combination works via complementary mechanisms. Epalrestat inhibits aldose reductase, the first enzyme in the polyol pathway, reducing the accumulation of sorbitol and fructose in nerves, which is implicated in osmotic stress, oxidative damage, and reduced nerve conduction velocity in hyperglycemia. Methylcobalamin acts as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase, essential for myelin synthesis, nucleic acid production, and nerve regeneration. It may also promote nerve repair. Pregabalin binds to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters (e.g., glutamate, substance P, noradrenaline), thereby dampening central sensitization and neuropathic pain signaling.
3. Indications & Uses
- Management of painful Diabetic Peripheral Neuropathy (DPN)
- Symptomatic treatment of neuropathic pain associated with diabetic neuropathy
4. Dosage & Administration
Adult Dosage: One tablet (Epalrestat 150mg + Methylcobalamin 1500mcg + Pregabalin 150mg) orally, twice daily. May be initiated at a lower dose (e.g., pregabalin 75mg) in some patients and titrated.
Administration: Administer orally with or without food. Swallow whole with a glass of water. Do not crush or chew. Can be taken after meals to minimize potential gastrointestinal discomfort. Adherence to a regular schedule is important for consistent pain control.
5. Side Effects
Common side effects may include:
- Dizziness
- Somnolence (drowsiness)
- Peripheral edema (swelling of hands/feet)
- Headache
- Nausea
- Dry mouth
- Weight gain (associated with pregabalin)
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Potentiated sedation, dizziness, respiratory depression, and impaired motor skills. | Major |
| Angiotensin-Converting Enzyme (ACE) Inhibitors (e.g., Ramipril, Enalapril) | Increased risk and severity of peripheral edema and angioedema. | Major |
| Thiazolidinediones (Pioglitazone, Rosiglitazone) | Additive risk of peripheral edema and weight gain. | Moderate |
| Levodopa | Methylcobalamin may reduce the efficacy of Levodopa in Parkinson's disease. | Moderate |
| Chloramphenicol | May antagonize the hematopoietic response to Methylcobalamin. | Moderate |
7. Patient Counselling
- DO take the medicine exactly as prescribed, at the same times each day.
- DO NOT stop taking the medicine suddenly; taper off under doctor's guidance to avoid withdrawal symptoms.
- DO inform all your doctors and surgeons (including dentists) that you are taking this medicine.
- DO NOT consume alcohol while on this medication.
- DO monitor your weight regularly and report sudden increases or swelling in limbs/face.
8. Toxicology & Storage
Overdose: Primarily driven by Pregabalin: Severe drowsiness, lethargy, agitation, confusion, depression, blurred vision, diplopia, seizures, coma. Bradycardia and heart block have been reported. Epalrestat/Methylcobalamin overdose is unlikely to cause severe toxicity.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach of children. Do not use after the expiry date printed on the pack.